Table 3.
EGFR mutations and clinicopathological feature of Tunisian NSCLC.
| Clinical Feature | Overall | Mutation (%) | Wt (%) | p-Value | |
|---|---|---|---|---|---|
| Gender | M | 65 (82.27) | 24 (36.9) | 41 (63.1) | 0.019 |
| F | 14 (17.72) | 10 (71.4) | 4 (28.6) | ||
| Age | <60 | 26 (32.91) | 10 (38.5) | 16 (61.5) | 0.307 |
| >60 | 33 (41.7) | 16 (48.5) | 17 (51.5) | ||
| Unknown | 20 (25.31) | 8 (40) | 12 (60) | ||
| Smoking History | Smoker | 45 (56.6) | 15 (33.3) | 30 (66.7) | 0.008 |
| Non-smoker | 24 (31.3) | 16 (61.5) | 10 (38.5) | ||
| Unknown | 10 (12) | 3 (30%) | 7 (70%) | ||
| Histological subtype | Adenocarcinoma | 51 (64.55) | 21 (41.2) | 30 (58.8) | 0.646 |
| Other subtypes | 5 (6.32) | 4 (80) | 1 (20) | ||
| Unknown | 23 (29.11) | 9 (39.1) | 14 (60.9) | ||
| Metastasis | Presence | 48 (60.75) | 26 (54.2) | 22 (45.8) | 0.044 |
| Absence | 21 (26.58) | 6 (28.6) | 15 (71.4) | ||
| Unknown | 10 (12) | 2 (20) | 8 (80) | ||